Prof. Luis Paz-Ares Rodríguez is a Spanish medical oncologist associated with Hospital Universitario 12 de Octubre in Madrid. He is known for his clinical, academic, and research work in medical oncology, particularly lung cancer and thoracic malignancies. He has served as head of the hospital's Medical Oncology Department since January 2015 and leads clinical and translational oncology research at the Instituto de Investigación Hospital 12 de Octubre 

Hospital Universitario 12 de Octubre

Medical Education and Professional Background

Prof. Paz-Ares completed his medical degree at the Autonomous University of Madrid, with studies documented from 1980 to 1986. His specialist training in Medical Oncology at Hospital Universitario 12 de Octubre is recorded from March 1988 through December 2001. He completed a doctorate in medicine in 1993 and subsequently undertook postgraduate study in clinical pharmacology at the University of Glasgow between 1993 and 1995.

His professional development combines hospital-based oncology, academic teaching, clinical research, and participation in collaborative cancer research programs. The hospital identifies him as a professor of medicine at the Complutense University of Madrid and as a leader in clinical and translational oncology.

Hospital Universitario 12 de Octubre

Medical Oncology and Lung Cancer

Medical oncology focuses on treating cancer through systemic therapies, including chemotherapy, targeted medicines, immunotherapy, and other individualized treatment approaches. Prof. Paz-Ares's principal area of clinical and research interest is thoracic oncology, especially lung cancer.

Lung cancer treatment depends on the cancer's type, stage, molecular characteristics, the patient's general health, and previous treatment history. Medical oncologists assess diagnostic findings and collaborate with thoracic surgeons, radiation oncologists, radiologists, pathologists, and other specialists to develop an appropriate treatment plan.

For patients with non-small-cell lung cancer, molecular testing may help identify alterations that can guide targeted treatment. Immunotherapy may also be considered for selected patients, depending on tumor characteristics and clinical circumstances. These approaches are not appropriate for every patient, and treatment decisions require individual evaluation.

Clinical and Translational Research

Prof. Paz-Ares has a documented research portfolio involving lung cancer therapies, targeted treatments, and clinical trials. His published work includes studies of therapies directed at molecular alterations in non-small-cell lung cancer and research evaluating treatment strategies for advanced disease. The hospital's oncology service incorporates clinical care, clinical trials, and translational research into its activities.

Hospital Universitario 12 de Octubre

Clinical research can help evaluate the safety and effectiveness of emerging therapies and improve understanding of cancer biology. Translational oncology seeks to connect laboratory discoveries with clinical applications, including the development of treatment strategies based on tumor characteristics.

For international patients, the availability of a particular clinical trial or medicine depends on eligibility criteria, current recruitment status, regulatory requirements, and the treating team's assessment. Participation should never be assumed solely from a physician's research interests.

Academic and Hospital Leadership

Since January 2015, Prof. Paz-Ares has held the position of head of Medical Oncology at Hospital Universitario 12 de Octubre. He has also led a mixed lung cancer unit involving the hospital and the Spanish National Cancer Research Centre (CNIO), with the unit's leadership documented from November 2015.

His academic work includes teaching at the Complutense University of Madrid and involvement in specialist oncology education. The hospital's Medical Oncology Department provides outpatient consultations, inpatient care, urgent oncology services, clinical trials, and supportive care.

Hospital Universitario 12 de Octubre

Care for International Patients

Patients travelling to Madrid for oncology consultations should prepare pathology reports, biopsy results, imaging studies, molecular profiling, previous treatment records, medication lists, and a concise medical history. These records help the medical team determine whether additional testing or a specialist consultation is appropriate.

A consultation does not guarantee eligibility for a particular treatment, clinical trial, or outcome. Treatment recommendations depend on the diagnosis, stage, prior therapies, and the patient's clinical condition.

Prof. Luis Paz-Ares Rodríguez's documented clinical leadership, academic involvement, and research focus make him a relevant physician to include in a directory of medical oncology specialists at Hospital Universitario 12 de Octubre.